Posts tagged amyloid precursor protein
Lilly's woes highlight the challenges of drug development

The recent announcement that Eli Lilly was halting all clinical testing of its Alzheimer's drug Semagacestat, was a body blow not only to Lilly, but also to the many other companies who are developing their own Alzheimer's medications.

Read More